Tectorigenin inhibits inflammation and pulmonary fibrosis in allergic asthma model of ovalbumin ‐sensitized guinea pigs

ConclusionsTectorigenin could inhibit pulmonary fibrosis and airway inflammation through TGF ‐β1/Smad signalling pathway and TLR4/NF‐κB signalling pathway. Therefore, tectorigenin might be a promising medicine to treat allergic asthma.

Source: Journal of Pharmacy and Pharmacology - June 7, 2020 Category: Drugs & Pharmacology Authors: Youpeng Wang, Weichao Jing, Wanying Qu, Zhiwei Liu, Di Zhang, Xiaoyu Qi, Lujia Liu Tags: Research Paper Source Type: research